Prospective association of serum and dietary magnesium with colorectal cancer incidence

Elizabeth J. Polter, Guillaume Onyeaghala, Pamela L. Lutsey, Aaron R. Folsom, Corinne E. Joshu, Elizabeth A Platz, Anna E. Prizment

Research output: Contribution to journalArticle

Abstract

Background: Laboratory and epidemiologic research suggests a protective role of magnesium in colorectal cancer development. We estimated the associations of serum and dietary magnesium with colorectal cancer incidence in the Atherosclerosis Risk in Communities (ARIC) study. Methods: Serum magnesium concentration was measured in blood collected twice (1987-1989 and 1990-1992) and averaged. Dietary magnesium was assessed by food-frequency questionnaire administered twice (1987-1989 and 1993- 1995) and averaged. For both dietary and serum magnesium, the averaged measures were categorized into quintiles for analysis. Analyses included 315 colorectal cancer cases among 13,009 participants for serum magnesium (followed for a medianof20.4 years), and 256 cases among 10,971 participants for dietary magnesium (followed for a median of 17.5 years). Cox proportional hazards regression was used to calculate multivariable-adjusted HRs and 95% confidence intervals (CI). Results: Multivariable-adjusted HRs (95% CI) of colorectal cancer for the highest four quintiles compared with the first quintile of serum magnesium were as follows: Q2: 0.70 (0.49-0.99); Q3: 0.68 (0.47-1.00); Q4: 0.87 (0.62-1.21); and Q5: 0.79 (0.57-1.11; Ptrend = 0.04). An inverse association was present in females (HR for Q5 vs. Q1: 0.59, 95% CI: 0.36-0.98, Ptrend = 0.01), but not males (HR for Q5 vs. Q1: 1.10, 95% CI: 0.67-1.79, Ptrend = 0.92; Pinteraction = 0.34). Dietary magnesium was not statistically significantly associated with colorectal cancer risk. Conclusions: Our study found a higher risk of colorectal cancer with lower serum magnesium among females, but not males. Impact: If our findings are confirmed, maintaining adequate serum magnesium levels may be important for colorectal cancer prevention.

Original languageEnglish (US)
Pages (from-to)1292-1299
Number of pages8
JournalCancer Epidemiology Biomarkers and Prevention
Volume28
Issue number8
DOIs
StatePublished - Jan 1 2019

Fingerprint

Magnesium
Colorectal Neoplasms
Incidence
Serum
Confidence Intervals
Atherosclerosis
Food

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Prospective association of serum and dietary magnesium with colorectal cancer incidence. / Polter, Elizabeth J.; Onyeaghala, Guillaume; Lutsey, Pamela L.; Folsom, Aaron R.; Joshu, Corinne E.; Platz, Elizabeth A; Prizment, Anna E.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 28, No. 8, 01.01.2019, p. 1292-1299.

Research output: Contribution to journalArticle

Polter, Elizabeth J. ; Onyeaghala, Guillaume ; Lutsey, Pamela L. ; Folsom, Aaron R. ; Joshu, Corinne E. ; Platz, Elizabeth A ; Prizment, Anna E. / Prospective association of serum and dietary magnesium with colorectal cancer incidence. In: Cancer Epidemiology Biomarkers and Prevention. 2019 ; Vol. 28, No. 8. pp. 1292-1299.
@article{5032c2218441480290e338dd01630a49,
title = "Prospective association of serum and dietary magnesium with colorectal cancer incidence",
abstract = "Background: Laboratory and epidemiologic research suggests a protective role of magnesium in colorectal cancer development. We estimated the associations of serum and dietary magnesium with colorectal cancer incidence in the Atherosclerosis Risk in Communities (ARIC) study. Methods: Serum magnesium concentration was measured in blood collected twice (1987-1989 and 1990-1992) and averaged. Dietary magnesium was assessed by food-frequency questionnaire administered twice (1987-1989 and 1993- 1995) and averaged. For both dietary and serum magnesium, the averaged measures were categorized into quintiles for analysis. Analyses included 315 colorectal cancer cases among 13,009 participants for serum magnesium (followed for a medianof20.4 years), and 256 cases among 10,971 participants for dietary magnesium (followed for a median of 17.5 years). Cox proportional hazards regression was used to calculate multivariable-adjusted HRs and 95{\%} confidence intervals (CI). Results: Multivariable-adjusted HRs (95{\%} CI) of colorectal cancer for the highest four quintiles compared with the first quintile of serum magnesium were as follows: Q2: 0.70 (0.49-0.99); Q3: 0.68 (0.47-1.00); Q4: 0.87 (0.62-1.21); and Q5: 0.79 (0.57-1.11; Ptrend = 0.04). An inverse association was present in females (HR for Q5 vs. Q1: 0.59, 95{\%} CI: 0.36-0.98, Ptrend = 0.01), but not males (HR for Q5 vs. Q1: 1.10, 95{\%} CI: 0.67-1.79, Ptrend = 0.92; Pinteraction = 0.34). Dietary magnesium was not statistically significantly associated with colorectal cancer risk. Conclusions: Our study found a higher risk of colorectal cancer with lower serum magnesium among females, but not males. Impact: If our findings are confirmed, maintaining adequate serum magnesium levels may be important for colorectal cancer prevention.",
author = "Polter, {Elizabeth J.} and Guillaume Onyeaghala and Lutsey, {Pamela L.} and Folsom, {Aaron R.} and Joshu, {Corinne E.} and Platz, {Elizabeth A} and Prizment, {Anna E.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1158/1055-9965.EPI-18-1300",
language = "English (US)",
volume = "28",
pages = "1292--1299",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Prospective association of serum and dietary magnesium with colorectal cancer incidence

AU - Polter, Elizabeth J.

AU - Onyeaghala, Guillaume

AU - Lutsey, Pamela L.

AU - Folsom, Aaron R.

AU - Joshu, Corinne E.

AU - Platz, Elizabeth A

AU - Prizment, Anna E.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Laboratory and epidemiologic research suggests a protective role of magnesium in colorectal cancer development. We estimated the associations of serum and dietary magnesium with colorectal cancer incidence in the Atherosclerosis Risk in Communities (ARIC) study. Methods: Serum magnesium concentration was measured in blood collected twice (1987-1989 and 1990-1992) and averaged. Dietary magnesium was assessed by food-frequency questionnaire administered twice (1987-1989 and 1993- 1995) and averaged. For both dietary and serum magnesium, the averaged measures were categorized into quintiles for analysis. Analyses included 315 colorectal cancer cases among 13,009 participants for serum magnesium (followed for a medianof20.4 years), and 256 cases among 10,971 participants for dietary magnesium (followed for a median of 17.5 years). Cox proportional hazards regression was used to calculate multivariable-adjusted HRs and 95% confidence intervals (CI). Results: Multivariable-adjusted HRs (95% CI) of colorectal cancer for the highest four quintiles compared with the first quintile of serum magnesium were as follows: Q2: 0.70 (0.49-0.99); Q3: 0.68 (0.47-1.00); Q4: 0.87 (0.62-1.21); and Q5: 0.79 (0.57-1.11; Ptrend = 0.04). An inverse association was present in females (HR for Q5 vs. Q1: 0.59, 95% CI: 0.36-0.98, Ptrend = 0.01), but not males (HR for Q5 vs. Q1: 1.10, 95% CI: 0.67-1.79, Ptrend = 0.92; Pinteraction = 0.34). Dietary magnesium was not statistically significantly associated with colorectal cancer risk. Conclusions: Our study found a higher risk of colorectal cancer with lower serum magnesium among females, but not males. Impact: If our findings are confirmed, maintaining adequate serum magnesium levels may be important for colorectal cancer prevention.

AB - Background: Laboratory and epidemiologic research suggests a protective role of magnesium in colorectal cancer development. We estimated the associations of serum and dietary magnesium with colorectal cancer incidence in the Atherosclerosis Risk in Communities (ARIC) study. Methods: Serum magnesium concentration was measured in blood collected twice (1987-1989 and 1990-1992) and averaged. Dietary magnesium was assessed by food-frequency questionnaire administered twice (1987-1989 and 1993- 1995) and averaged. For both dietary and serum magnesium, the averaged measures were categorized into quintiles for analysis. Analyses included 315 colorectal cancer cases among 13,009 participants for serum magnesium (followed for a medianof20.4 years), and 256 cases among 10,971 participants for dietary magnesium (followed for a median of 17.5 years). Cox proportional hazards regression was used to calculate multivariable-adjusted HRs and 95% confidence intervals (CI). Results: Multivariable-adjusted HRs (95% CI) of colorectal cancer for the highest four quintiles compared with the first quintile of serum magnesium were as follows: Q2: 0.70 (0.49-0.99); Q3: 0.68 (0.47-1.00); Q4: 0.87 (0.62-1.21); and Q5: 0.79 (0.57-1.11; Ptrend = 0.04). An inverse association was present in females (HR for Q5 vs. Q1: 0.59, 95% CI: 0.36-0.98, Ptrend = 0.01), but not males (HR for Q5 vs. Q1: 1.10, 95% CI: 0.67-1.79, Ptrend = 0.92; Pinteraction = 0.34). Dietary magnesium was not statistically significantly associated with colorectal cancer risk. Conclusions: Our study found a higher risk of colorectal cancer with lower serum magnesium among females, but not males. Impact: If our findings are confirmed, maintaining adequate serum magnesium levels may be important for colorectal cancer prevention.

UR - http://www.scopus.com/inward/record.url?scp=85070536627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070536627&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-18-1300

DO - 10.1158/1055-9965.EPI-18-1300

M3 - Article

VL - 28

SP - 1292

EP - 1299

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 8

ER -